Acasti Pharma | ACST - Pre Tax Profit

Stock Price
4.12
Daily Change
0 0%
Monthly
9.57%
Yearly
36.42%
Q1 Forecast
3.78

Acasti Pharma reported $-938K in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Acasti Pharma USD -938K 2.42M Sep/2025
Addus HomeCare USD 30.35M 405K Sep/2025
Amarin USD -8.12M 5.34M Sep/2025
Cassava Sciences USD -10.81M 33.41M Sep/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Option Care Health USD 68.97M 109K Sep/2025
Organigram Holdings CAD -41.72M 25.52M Sep/2025
Tilray USD -1.39B 600.71M Mar/2025